Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease

References

• Lipshultz SE, Sleeper LA, Towbin JA et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N. Engl. J. Med.348(17), 1647–1655 (2003).
   PubMed Web of Science ®Google Scholar
• Boucek MM, Edwards LB, Keck BM et al. The Registry of the International Society for Heart and Lung Transplantation: Sixth Official Pediatric Report – 2003. J. Heart Lung Transplant.22(6), 636–652 (2003).
   Google Scholar
• Rosenthal DN, Dubin AM, Chin C, Falco D, Gamberg P, Bernstein D. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J. Heart Lung Transplant.19(8), 751–755 (2000).
   Google Scholar
• Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. Prog. Pediatr. Cardiol.11(2), 99–105 (2000).
   Google Scholar
• Steinberger J, Haines HC, Shumway SJ, Bolman RM, 3rd, Rocchini AP, Braunlin EA. Outcome after referral for pediatric transplantation. J. Heart Lung Transplant.12(5), 766–769 (1993).
   Google Scholar
• Nield LE, McCrindle BW, Bohn DJ, et al. Outcomes for children with cardiomyopathy awaiting transplantation. Cardiol. Young. 10(4), 358–366 (2000).
   Web of Science ®Google Scholar
• Dubin AM, Van Hare GF, Collins KK, Bernstein D, Rosenthal DN. Survey of current practices in use of amiodarone and implantable cardioverter defibrillators in pediatric patients with end-stage heart failure. Am. J. Cardiol.88(7), 809–810 (2001).
   Google Scholar
• Dubin AM, Janousek J, Rhee E et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J. Am. Coll. Cardiol.46(12), 2277–2283 (2005).
   PubMed Web of Science ®Google Scholar
• Janousek J, Paul T, Reimer A, Kallfelz HC. Usefulness of propafenone for supraventricular arrhythmias in infants and children. Am. J. Cardiol.72(3), 294–300 (1993).
   PubMed Web of Science ®Google Scholar
• Perry JC, Garson A Jr. Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing. Am. Heart J.124(6), 1614–1621 (1992).
   Google Scholar
• Perry JC, Knilans TK, Marlow D, Denfield SW, Fenrich AL, Friedman RA. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. J. Am. Coll. Cardiol.22(1), 95–98 (1993).
   Google Scholar
• Vrobel TR, Miller PE, Mostow ND, Rakita L. A general overview of amiodarone toxicity: its prevention, detection, and management. Prog. Cardiovasc. Dis.31(6), 393–426 (1989).
   PubMedGoogle Scholar
• Kirsh JA, Gross GJ, O'Connor S, Hamilton RM. Transcatheter cryoablation of tachyarrhythmias in children: initial experience from an international registry. J. Am. Coll. Cardiol.45(1), 133–136 (2005).
   PubMed Web of Science ®Google Scholar
• Kugler JD, Danford DA, Deal BJ et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N. Engl. J. Med.330(21), 1481–1487 (1994).
   PubMed Web of Science ®Google Scholar
• Weipert J, Noebauer C, Schreiber C, et al. Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J. Thorac. Cardiovasc. Surg.127(2), 457–464 (2004).
   PubMedGoogle Scholar
• Triedman JK, Saul JP, Weindling SN, Walsh EP. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation91(3), 707–714 (1995).
   PubMedGoogle Scholar
• DiCarlo LA, Jr., Morady F, Krol RB, et al. The hemodynamic effects of ventricular pacing with and without atrioventricular synchrony in patients with normal and diminished left ventricular function. Am. Heart J.114(4 Pt 1), 746–752 (1987).
   Google Scholar
• Stephenson EA, Casavant D, Tuzi J et al. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am. J. Cardiol.92(7), 871–876 (2003).
   PubMed Web of Science ®Google Scholar
• Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J. Thorac. Cardiovasc. Surg.122(5), 863–871 (2001).
   PubMed Web of Science ®Google Scholar
• Collins KK, Rhee EK, Delucca JM et al. Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J. Thorac. Cardiovasc. Surg.127(3), 721–729 (2004).
   PubMed Web of Science ®Google Scholar
• Weinstein S, Cua C, Chan D, Davis JT. Outcome of symptomatic patients undergoing extracardiac Fontan conversion and cryoablation. J. Thorac. Cardiovasc. Surg.126(2), 529–536 (2003).
   Google Scholar
• Sheikh AM, Tang AT, Roman K et al. The failing Fontan circulation: successful conversion of atriopulmonary connections. J. Thorac. Cardiovasc. Surg.128(1), 60–66 (2004).
   Google Scholar
• Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am. J. Cardiol.68(4), 365–369 (1991).
   Web of Science ®Google Scholar
• Griffin ML, Hernandez A, Martin TC et al. Dilated cardiomyopathy in infants and children. J. Am. Coll. Cardiol.11(1), 139–144 (1988).
   Web of Science ®Google Scholar
• Friedman RA, Moak JP, Garson A, Jr. Clinical course of idiopathic dilated cardiomyopathy in children. J. Am. Coll. Cardiol.18(1), 152–156 (1991).
   Google Scholar
• Muller G, Ulmer HE, Hagel KJ, Wolf D. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy. Pediatr. Cardiol.16(2), 56–60 (1995).
   Google Scholar
• Hayes CJ, Gersony WM. Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study. J. Am. Coll. Cardiol.7(1), 133–137 (1986).
   Google Scholar
• Garson A, Jr., Randall DC, Gillette PC et al. Prevention of sudden death after repair of tetralogy of Fallot: treatment of ventricular arrhythmias. J. Am. Coll. Cardiol.6(1), 221–227 (1985).
   PubMed Web of Science ®Google Scholar
• Gillette PC, Yeoman MA, Mullins CE, McNamara DG. Sudden death after repair of tetralogy of Fallot. Electrocardiographic and electrophysiologic abnormalities. Circulation56(4 Pt 1), 566–571 (1977).
   Google Scholar
• Sullivan ID, Presbitero P, Gooch VM, Aruta E, Deanfield JE. Is ventricular arrhythmia in repaired tetralogy of Fallot an effect of operation or a consequence of the course of the disease? A prospective study. Br. Heart J.58(1), 40–44 (1987).
   Google Scholar
• Deanfield JE, Ho SY, Anderson RH, McKenna WJ, Allwork SP, Hallidie-Smith KA. Late sudden death after repair of tetralogy of Fallot: a clinicopathologic study. Circulation67(3), 626–631 (1983).
   PubMed Web of Science ®Google Scholar
• Wiles HB, Gillette PC, Harley RA, Upshur JK. Cardiomyopathy and myocarditis in children with ventricular ectopic rhythm. J. Am. Coll. Cardiol.20(2), 359–362 (1992).
   PubMedGoogle Scholar
• Dyckner T, Wester PO. Potassium/magnesium depletion in patients with cardiovascular disease. Am. J. Med.82(3A), 11–17 (1987).
   PubMed Web of Science ®Google Scholar
• Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA283(10), 1295–1302 (2000).
   PubMed Web of Science ®Google Scholar
• Packer M, Coats AJ, Fowler MB et al. Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med.344(22), 1651–8 (2001).
   PubMed Web of Science ®Google Scholar
• Rusconi P, Gomez-Marin O, Rossique-Gonzalez M, et al. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution. J. Heart Lung Transplant.23(7), 832–838 (2004).
   PubMed Web of Science ®Google Scholar
• Azeka E, Franchini Ramires JA, Valler C, Alcides Bocchi E. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J. Am. Coll. Cardiol.40(11), 2034–2038 (2002).
   Google Scholar
• Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J. Pediatr.138(4), 505–511 (2001).
   PubMed Web of Science ®Google Scholar
• Shaddy RE, Curtin EL, Sower B, et al. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design. Am. Heart J.144(3), 383–389 (2002).
   PubMed Web of Science ®Google Scholar
• Shaddy RE, Hsu DT, Boucek R et al. Multicenter Randomized Placebo-Controlled Double-Blind Trial of Carvedilol in Children with Heart Failure. In: 2006 Annual Scientific Sessions of the American College of Caridology, Atlanta, GA, USA (2006).
   Google Scholar
• Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N. Engl. J. Med.324(12), 781–788 (1991).
   PubMed Web of Science ®Google Scholar
• Fish FA, Gillette PC, Benson DW, Jr. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J. Am. Coll. Cardiol.18(2), 356–365 (1991).
   PubMed Web of Science ®Google Scholar
• Figa FH, Gow RM, Hamilton RM, Freedom RM. Clinical efficacy and safety of intravenous Amiodarone in infants and children. Am. J. Cardiol.74(6), 573–577 (1994).
   Google Scholar
• Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am. Heart J.100(6 Pt 2), 1063–1069 (1980).
   Google Scholar
• Saul JP, Scott WA, Brown S, et al. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation112(22), 3470–3477 (2005).
   PubMed Web of Science ®Google Scholar
• Saul JP, Ross B, Schaffer MS, et al. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia. Clin. Pharmacol. Ther.69(3), 145–157 (2001).
   Google Scholar
• Tanel RE, Walsh EP, Lulu JA, Saul JP. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Am. Heart J.130(4), 791–797 (1995).
   Google Scholar
• Morwood JG, Triedman JK, Berul CI, et al. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease.Heart Rhythm1(3), 301–308 (2004).
   PubMed Web of Science ®Google Scholar
• Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med.341(25), 1882–1890 (1999).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med.346(12), 877–883 (2002).
   PubMed Web of Science ®Google Scholar
• Lorga-Filho A, Geelen P, Vanderheyden M, et al. Early benefit of implantable cardioverter defibrillator therapy in patients waiting for cardiac transplantation. Pacing Clin. Electrophysiol.21(9), 1747–50 (1998).
   Google Scholar
• Forni A, Faggian G, Luciani GB, Lamascese N, Chiominto B, Mazzucco A. Safety and efficacy of automatic implantable defibrillator used as a bridge to heart transplant. Transplant Proc.33(4), 2489–2492 (2001).
   Google Scholar
• Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med.352(3), 225–237 (2005).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med.335(26), 1933–1940 (1996).
   PubMed Web of Science ®Google Scholar
• Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med.350(21), 2151–2158 (2004).
   PubMed Web of Science ®Google Scholar
• Aranda JM, Jr., Woo GW, Schofield RS et al. Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function. J. Am. Coll. Cardiol.46(12), 2193–2198 (2005).
   Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med.352(15), 1539–1549 (2005).
   PubMed Web of Science ®Google Scholar
• Leon AR, Abraham WT, Curtis AB et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J. Am. Coll. Cardiol.46(12), 2348–2356 (2005).
   Google Scholar
• Carson P, Anand I, O'Connor C et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J. Am. Coll. Cardiol.46(12), 2329–2334 (2005).
   PubMed Web of Science ®Google Scholar
• Dubin AM, Berul CI, Bevilacqua LM et al. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. J. Card. Fail.9(5), 375–379 (2003).
   PubMed Web of Science ®Google Scholar
• Link MS, Hill SL, Cliff DL et al. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am. J. Cardiol.83(2), 263–266, A5–6 (1999).
   PubMed Web of Science ®Google Scholar
• Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J. Cardiovasc. Electrophysiol.15(1), 72–76 (2004).
   PubMed Web of Science ®Google Scholar
• Berul CI, Triedman JK, Forbess J et al. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin. Electrophysiol.24(12), 1789–1794 (2001).
   PubMed Web of Science ®Google Scholar
• Stephenson EA, Batra AS, Knilans TK et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in pediatric and congenital heart disease populations. J. Cardiovasc. Electrophysiol.17, 41–46 (2006).
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med.350(21), 2140–2150 (2004).
   PubMed Web of Science ®Google Scholar
• Cazeau S, Ritter P, Lazarus A, et al. Multisite pacing for end-stage heart failure: early experience. Pacing Clin. Electrophysiol.19(11 Pt 2), 1748–1757 (1996).
   PubMedGoogle Scholar
• Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med.344(12), 873–880 (2001).
   PubMed Web of Science ®Google Scholar
• Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation96(10), 3273–3277 (1997).
   PubMed Web of Science ®Google Scholar
• Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation99(12), 1567–1573 (1999).
   PubMed Web of Science ®Google Scholar
• Nelson GS, Berger RD, Fetics BJ et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation102(25), 3053–3059 (2000).
   PubMed Web of Science ®Google Scholar
• Young JB, Abraham WT, Smith AL et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA289(20), 2685–2694 (2003).
   PubMed Web of Science ®Google Scholar
• Alexander ME, Berul CI, Fortescue EB et al. Who is eligible for cardiac resyncrhonizationtherapy in pediatric cardiology? Heart Rhythm1(1S), S122 (2004).
   Google Scholar
• Zimmerman FJ, Starr JP, Koenig PR, Smith P, Hijazi ZM, Bacha EA. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann. Thorac. Surg.75(6), 1775–1780 (2003).
   Google Scholar
• Janousek J, Vojtovic P, Hucin B et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am. J. Cardiol.88(2), 145–152 (2001).
   PubMed Web of Science ®Google Scholar
• Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation107(18), 2287–2289 (2003).
   PubMed Web of Science ®Google Scholar
• Bacha EA, Zimmerman FJ, Mor-Avi V et al. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann. Thorac. Surg.78(5), 1678–1683 (2004).
   PubMed Web of Science ®Google Scholar
• Stephenson EA, Cecchin F, Alexander ME, Triedman JK, Walsh EP, Berul CI. Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Am. J. Cardiol.93(11), 1449–1152, A12 (2004).
   Google Scholar
• Sun JP, Chinchoy E, Donal E, et al. Evaluation of ventricular synchrony using novel Doppler echocardiographic indices in patients with heart failure receiving cardiac resynchronization therapy. J. Am. Soc. Echocardiogr.17(8), 845–850 (2004).
   PubMedGoogle Scholar
• Pham PP, Balaji S, Shen I, Ungerleider R, Li X, Sahn DJ. Impact of conventional versus biventricular pacing on hemodynamics and tissue Doppler imaging indexes of resynchronization postoperatively in children with congenital heart disease. J. Am. Coll. Cardiol.46(12), 2284–2289 (2005).
   Google Scholar
• Rhee EK. Cardiac resynchronization therapy in pediatrics: emerging technologies for emerging indications. Curr. Treat. Options Cardiovasc. Med.7(5), 399–409 (2005).
   Google Scholar
• Khairy P, Fournier A, Thibault B, Dubuc M, Therien J, Vobecky SJ. Cardiac resynchronization therapy in congenital heart disease. Int. J. Cardiol.109(2), 160–168 (2006).
   PubMedGoogle Scholar
• Janousek J, Tomek V, Chaloupecky VA, et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J. Am. Coll. Cardiol.44(9), 1927–1931 (2004).
   PubMedGoogle Scholar